# Effect of Two Different Doses of Dexamethasone in Patients With ARDS and COVID-19

> **NCT04663555** · PHASE4 · COMPLETED · sponsor: **Brno University Hospital** · enrollment: 235 (actual)

## Conditions studied

- Covid19
- ARDS

## Interventions

- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT04663555
- **Lead sponsor:** Brno University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-02
- **Primary completion:** 2022-03-09
- **Final completion:** 2023-02-23
- **Target enrollment:** 235 (ACTUAL)
- **Last updated:** 2023-03-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04663555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04663555, "Effect of Two Different Doses of Dexamethasone in Patients With ARDS and COVID-19". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04663555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*